n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases
Cytiva donates equipment totaling $415,000 [...]
n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare Diseases
Argonaut to support n-Lorem’s expanding [...]
n-Lorem Foundation Announces New Publication in Trends in Molecular Medicine
Publication highlights the [...]
John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council
John Maraganore pledges [...]
n-Lorem Foundation Welcomes New Members, Jason Wood and Gene Yeo, to its Board of Directors
Newest members contribute [...]
n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer
Experienced research geneticist [...]
n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases
World’s largest oligonucleotide [...]
